scispace - formally typeset
X

Xiaorong Guo

Researcher at Harbin Medical University

Publications -  5
Citations -  110

Xiaorong Guo is an academic researcher from Harbin Medical University. The author has contributed to research in topics: Cancer & microRNA. The author has an hindex of 4, co-authored 5 publications receiving 51 citations.

Papers
More filters
Journal ArticleDOI

MicroRNA-124: An emerging therapeutic target in cancer.

TL;DR: This review focuses on the specific molecular functions of miR‐124 and the downstream gene targets in major cancers, which provide preclinical evidence for the treatment of human cancer.
Journal ArticleDOI

Comprehensive analysis of the SLC16A gene family in pancreatic cancer via integrated bioinformatics.

TL;DR: The expression profile, clinical application significance and prognostic value of the SLC16A family for patients with pancreatic cancer were explored, and their related genes and regulatory networks were identified, revealing core molecular pathways that require further investigation for pancreaticcancer.
Journal ArticleDOI

Fusobacterium nucleatum, the communication with colorectal cancer.

TL;DR: Fusobacterium nucleatum (F.n), an anaerobe, is found to be enriched in both stools and tumor tissues of CRC patients and could be a biomarker of CRC.
Journal ArticleDOI

The multifaceted roles of long noncoding RNAs in pancreatic cancer: an update on what we know

TL;DR: The current understanding of the multifaceted roles of lncRNAs as regulators in the molecular mechanism of PC is addressed and the possibility of using lnc RNAs as survival biomarkers and their contributions to the development of targeted therapies based on the literature are discussed.
Journal ArticleDOI

SLC15A4 Serves as a Novel Prognostic Biomarker and Target for Lung Adenocarcinoma.

TL;DR: Wang et al. as mentioned in this paper investigated the SLC15A family members in lung cancer through accumulated data from TCGA and other available online databases by integrated bioinformatics analysis to reveal the prognostic value, potential clinical application and underlying molecular mechanisms of SLC 15A family member in lung Cancer.